You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 154 No. 21, 14 November 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Articles
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Management of Adverse Reactions to Trimethoprim-Sulfamethoxazole in Human Immunodeficiency Virus—Infected Patients

Alan C. Jung, MD; Douglas S. Paauw, MD

Arch Intern Med. 1994;154(21):2402-2406.


Abstract

Trimethoprim-sulfamethoxazole is an important medication for the treatment and prevention of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Use of this medication has been limited by the high frequency of adverse reactions that occur in patients with human immunodeficiency virus disease. This article reviews the incidence and spectrum of adverse reactions and options for continuing therapy with trimethoprim-sulfamethoxazole in human immunodeficiency virus—infected patients who have adverse reactions. (Arch Intern Med. 1994;154:2402-2406)



Author Affiliations

From the Department of Medicine, University of Washington, Seattle.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Trimethoprim-Sulfamethoxazole Revisited
Masters et al.
Arch Intern Med 2003;163:402-410.
ABSTRACT | FULL TEXT  

Prophylaxis for Human Immunodeficiency Virus-Related Pneumocystis carinii Pneumonia: Using Simulation Modeling to Inform Clinical Guidelines
Goldie et al.
Arch Intern Med 2002;162:921-928.
ABSTRACT | FULL TEXT  

Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome: Does Early Withdrawal of Causative Drugs Decrease the Risk of Death?
Garcia-Doval et al.
Arch Dermatol 2000;136:323-327.
ABSTRACT | FULL TEXT  

Efficacy and Safety of Desensitization With Sulfamethoxazole and Trimethoprim in 48 Previously Hypersensitive Patients Infected With Human Immunodeficiency Virus
Caumes et al.
Arch Dermatol 1997;133:465-469.
ABSTRACT  

Trimethoprim-Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's Granulomatosis
Stegeman et al.
NEJM 1996;335:16-20.
ABSTRACT | FULL TEXT  

A Meta-analysis of the Relative Efficacy and Toxicity of Pneumocystis carinii Prophylactic Regimens
Ioannidis et al.
Arch Intern Med 1996;156:177-188.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.